Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7709568

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
Key financial data of group
Business results of group
Net sales
92,549,000,000 JPY
94,165,000,000 JPY
96,891,000,000 JPY
98,430,000,000 JPY
99,949,000,000 JPY
101,479,000,000 JPY
107,627,000,000 JPY
109,730,000,000 JPY
91,951,000,000 JPY
93,889,000,000 JPY
Ordinary profit (loss)
24,850,000,000 JPY
24,972,000,000 JPY
27,747,000,000 JPY
27,854,000,000 JPY
30,863,000,000 JPY
30,981,000,000 JPY
34,743,000,000 JPY
35,365,000,000 JPY
19,845,000,000 JPY
20,394,000,000 JPY
Profit (loss) attributable to owners of parent
17,775,000,000 JPY
19,043,000,000 JPY
22,017,000,000 JPY
21,143,000,000 JPY
12,122,000,000 JPY
Comprehensive income
16,782,000,000 JPY
20,753,000,000 JPY
22,587,000,000 JPY
18,444,000,000 JPY
16,607,000,000 JPY
Net assets
121,131,000,000 JPY
120,948,000,000 JPY
113,763,000,000 JPY
113,874,000,000 JPY
102,655,000,000 JPY
103,424,000,000 JPY
89,875,000,000 JPY
91,103,000,000 JPY
79,069,000,000 JPY
77,100,000,000 JPY
Total assets
155,985,000,000 JPY
154,347,000,000 JPY
150,808,000,000 JPY
152,417,000,000 JPY
135,060,000,000 JPY
133,157,000,000 JPY
132,991,000,000 JPY
130,838,000,000 JPY
115,834,000,000 JPY
115,135,000,000 JPY
Net assets per share
3,049.78
3,045.17
2,821.57
2,824.32
2,511.68
2,530.50
2,170.60
2,200.25
1,908.66
1,861.12
Basic earnings (loss) per share
443.80
445.78
468.84
470.54
534.84
536.70
452.92
510.54
282.61
290.90
Diluted earnings per share
Equity-to-asset ratio
0.777 xbrli:pure
0.784 xbrli:pure
0.754 xbrli:pure
0.747 xbrli:pure
0.760 xbrli:pure
0.777 xbrli:pure
0.676 xbrli:pure
0.696 xbrli:pure
0.683 xbrli:pure
0.670 xbrli:pure
Rate of return on equity
0.151 xbrli:pure
0.151 xbrli:pure
0.175 xbrli:pure
0.176 xbrli:pure
0.226 xbrli:pure
0.229 xbrli:pure
0.220 xbrli:pure
0.253 xbrli:pure
0.156 xbrli:pure
0.167 xbrli:pure
Price-earnings ratio
11.3 xbrli:pure
11.3 xbrli:pure
13.4 xbrli:pure
13.3 xbrli:pure
11.8 xbrli:pure
11.7 xbrli:pure
15.0 xbrli:pure
13.3 xbrli:pure
24.6 xbrli:pure
23.9 xbrli:pure
Net cash provided by (used in) operating activities
21,129,000,000 JPY
21,703,000,000 JPY
15,327,000,000 JPY
27,067,000,000 JPY
14,737,000,000 JPY
Net cash provided by (used in) investing activities
-5,744,000,000 JPY
-3,245,000,000 JPY
-3,503,000,000 JPY
-4,105,000,000 JPY
473,000,000 JPY
Net cash provided by (used in) financing activities
-9,524,000,000 JPY
-9,530,000,000 JPY
-9,800,000,000 JPY
-5,984,000,000 JPY
-7,900,000,000 JPY
Cash and cash equivalents
58,555,000,000 JPY
52,694,000,000 JPY
43,767,000,000 JPY
41,744,000,000 JPY
24,767,000,000 JPY
Number of employees
1,341 xbrli:pure
xbrli:pure
1,341 xbrli:pure
xbrli:pure
1,333 xbrli:pure
1,333 xbrli:pure
1,382 xbrli:pure
1,389 xbrli:pure
1,405 xbrli:pure
1,398 xbrli:pure
1,451 xbrli:pure
1,444 xbrli:pure
1,493 xbrli:pure
1,503 xbrli:pure
Average number of temporary employees
262 xbrli:pure
1 xbrli:pure
261 xbrli:pure
1 xbrli:pure
259 xbrli:pure
260 xbrli:pure
280 xbrli:pure
284 xbrli:pure
298 xbrli:pure
294 xbrli:pure
309 xbrli:pure
306 xbrli:pure
301 xbrli:pure
304 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.